{"nct_id":"NCT06061809","title":"N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-09","start_date":"2024-08-07","start_date_type":"ACTUAL","primary_completion_date":"2029-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2030-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["IBRX"]}